epilepsy | cpnp.org

Home
About CPNP
- Why Join CPNP
- Board of Directors
- Past Presidents
- Committees & Task Forces
- Awards
- CPNP Foundation
- Corporate Sponsorships
  - Sponsor Program
  - Sponsors
- Information for Patients
- Contact CPNP
Education
- April 2013 Annual Meeting in Colorado Springs, CO
- April 2014 Annual Meeting in Phoenix, AZ
- CPNP University Online Courses
- Drug-Induced Movement Disorders Training DVD
- Psychiatric Pharmacotherapy for Nurses
- Other Meetings
- Find More Resources in My CPNP
  - My CPNP Presentations & Exams
  - My CPNP ACPE Transcript Center
BCPP
- BCPP Exam Preparation
  - BCPP Exam Preparation
  - Certification FAQ
- BCPP Recertification
Careers/Residencies
Member Center
- Join or Renew
- Member Toolkit
- Email List
- Member Directory
- CPNP Documents and Reports
- Member Hubs
  - Pharmacy Student Hub
  - New Practitioner Hub
Resources
Gov't and Prof Affairs
- Comprehensive Medication Management
- Government Affairs
  - Contacting Legislators and Policy Makers
  - Medicare Coverage Initiative with ACCP
- Position/White Papers
  - Psychiatric Pharmacy Manifesto
  - Psychiatric Pharmacist Integration into the Medical Home Model
My CPNP
- Edit My Profile
- My Disclosures of Interest
- My Workspaces
- My Presentations & Exams
- My Volunteer Profile
- My CPNP Transcript Center
- My Opportunities

epilepsy

MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion.

Löscher W, Delanty N. MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion. Pharmacogenomics. 2009;10(5):711-3. doi:10.2217/pgs.09.47.

Side effects of sodium valproate in monotherapy controlled by plasma levels: a study in 88 pediatric patients.

Herranz JL, Arteaga R, Armijo JA. Side effects of sodium valproate in monotherapy controlled by plasma levels: a study in 88 pediatric patients. Epilepsia. 1982;23(2):203-14. Available at: .

The treatment of depressive disorders in epilepsy: what all neurologists should know.

Kanner AM. The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia. 2013;54 Suppl 1:3-12. doi:10.1111/epi.12100.

Introduction--Treatment of psychiatric disorders in adults with epilepsy: what every epileptologist should know.

Mula M, Kanner AM. Introduction--Treatment of psychiatric disorders in adults with epilepsy: what every epileptologist should know. Epilepsia. 2013;54 Suppl 1:1-2. doi:10.1111/epi.12099.

Basic treatment principles for psychotic disorders in patients with epilepsy.

Adachi N, Kanemoto K, de Toffol B, et al. Basic treatment principles for psychotic disorders in patients with epilepsy. Epilepsia. 2013;54 Suppl 1:19-33. doi:10.1111/epi.12102.

Treatment of anxiety disorders in epilepsy: an evidence-based approach.

Mula M. Treatment of anxiety disorders in epilepsy: an evidence-based approach. Epilepsia. 2013;54 Suppl 1:13-8. doi:10.1111/epi.12101.

Treatment of behavioral problems in intellectually disabled adult patients with epilepsy.

Kerr M, Gil-Nagel A, Glynn M, et al. Treatment of behavioral problems in intellectually disabled adult patients with epilepsy. Epilepsia. 2013;54 Suppl 1:34-40. doi:10.1111/epi.12103.

Treatment of postsurgical psychiatric complications.

Koch-Stoecker S, Schmitz B, Kanner AM. Treatment of postsurgical psychiatric complications. Epilepsia. 2013;54 Suppl 1:46-52. doi:10.1111/epi.12105.

Treatment issues for personality disorders in epilepsy.

Trimble M. Treatment issues for personality disorders in epilepsy. Epilepsia. 2013;54 Suppl 1:41-5. doi:10.1111/epi.12104.

Author reply.

Kelley SA. Author reply. Neurology. 2013;80(4):421. Available at: .